Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
British drugs giant Shire is looking at ways of giving as much as £2billion back to its shareholders to bolster its defences against a possible foreign takeover bid. New chief executive Flemming Ornskov has begun asking investment banking advisers to draw up plans on how the FTSE 100 company should return some of its cash pile, including a possible special dividend. The move comes amid mounting speculation that an American pharmaceutical business is ready to pounce on Shire, which makes drugs to treat attention deficit hyperactivity disorder (ADHD), in an £11billion hostile takeover bid. It has been reported that US-based Bristol-Myers Squibb engaged advisers to study an acquisition of Shire.
Help employers find you! Check out all the jobs and post your resume.
